Ovarian Ablation for Premenopausal Breast Cancer: A Review of Treatment Considerations and the Impact of Premature Menopause

Highlights • Ovarian ablation (OA) is an important treatment for premenopausal breast cancer. • The 5-year survival benefit of OA as an adjuvant therapy is limited (1.4-3.6%). • OA causes premature menopause resulting in side effects and mortality risks. • Women contemplating OA require a comprehens...

Full description

Saved in:
Bibliographic Details
Published inCancer treatment reviews Vol. 55; pp. 26 - 35
Main Authors Nourmoussavi, Melica, MD, Pansegrau, Gary, MD, Popesku, Jason, PhD, Hammond, Geoffrey L., PhD, Kwon, Janice S., MD, Carey, Mark S., MD
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights • Ovarian ablation (OA) is an important treatment for premenopausal breast cancer. • The 5-year survival benefit of OA as an adjuvant therapy is limited (1.4-3.6%). • OA causes premature menopause resulting in side effects and mortality risks. • Women contemplating OA require a comprehensive risk/benefit discussion.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0305-7372
1532-1967
DOI:10.1016/j.ctrv.2017.02.005